Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.45 USD | +1.30% | +3.37% | +35.47% |
09/09 | UBS Raises Price Target on Philip Morris International to $105 From $95, Maintains Sell Rating | MT |
09/09 | Philip Morris: the number of counterfeit cigarettes in Europe is a cause for concern | CF |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 29.8B | 28.69B | 31.4B | 31.76B | 35.17B | |||||
Total Revenues | 29.8B | 28.69B | 31.4B | 31.76B | 35.17B | |||||
Cost of Goods Sold, Total | 10.51B | 9.57B | 10.03B | 11.23B | 12.88B | |||||
Gross Profit | 19.29B | 19.12B | 21.38B | 20.53B | 22.3B | |||||
Selling General & Admin Expenses, Total | 8.36B | 7.33B | 8.2B | 8.14B | 9.6B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 66M | 73M | 96M | - | - | |||||
Other Operating Expenses, Total | 8.43B | 7.4B | 8.3B | 8.14B | 9.6B | |||||
Operating Income | 10.86B | 11.72B | 13.08B | 12.4B | 12.7B | |||||
Interest Expense, Total | -796M | -728M | -737M | -768M | -1.53B | |||||
Interest And Investment Income | 226M | 110M | 109M | 180M | 465M | |||||
Net Interest Expenses | -570M | -618M | -628M | -588M | -1.06B | |||||
Income (Loss) On Equity Invest. | 149M | 16M | 149M | 137M | 157M | |||||
EBT, Excl. Unusual Items | 10.44B | 11.12B | 12.6B | 11.94B | 11.79B | |||||
Restructuring Charges | -422M | -149M | -216M | - | -109M | |||||
Impairment of Goodwill | - | - | - | - | -665M | |||||
Asset Writedown | - | - | - | -112M | -15M | |||||
Legal Settlements | - | - | - | - | -204M | |||||
Other Unusual Items | - | - | - | -62M | -193M | |||||
EBT, Incl. Unusual Items | 10.02B | 10.97B | 12.38B | 11.77B | 10.61B | |||||
Income Tax Expense | 2.29B | 2.38B | 2.67B | 2.24B | 2.34B | |||||
Earnings From Continuing Operations | 7.73B | 8.59B | 9.71B | 9.53B | 8.27B | |||||
Net Income to Company | 7.73B | 8.59B | 9.71B | 9.53B | 8.27B | |||||
Minority Interest | -543M | -536M | -601M | -479M | -455M | |||||
Net Income - (IS) | 7.18B | 8.06B | 9.11B | 9.05B | 7.81B | |||||
Preferred Dividend and Other Adjustments | 17M | 20M | 26M | 24M | 22M | |||||
Net Income to Common Incl Extra Items | 7.17B | 8.04B | 9.08B | 9.02B | 7.79B | |||||
Net Income to Common Excl. Extra Items | 7.17B | 8.04B | 9.08B | 9.02B | 7.79B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.61 | 5.16 | 5.83 | 5.82 | 5.02 | |||||
Basic EPS - Continuing Operations | 4.61 | 5.16 | 5.83 | 5.82 | 5.02 | |||||
Basic Weighted Average Shares Outstanding | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | |||||
Net EPS - Diluted | 4.61 | 5.16 | 5.83 | 5.81 | 5.02 | |||||
Diluted EPS - Continuing Operations | 4.61 | 5.16 | 5.83 | 5.81 | 5.02 | |||||
Diluted Weighted Average Shares Outstanding | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | |||||
Normalized Basic EPS | 3.85 | 4.12 | 4.67 | 4.51 | 4.46 | |||||
Normalized Diluted EPS | 3.85 | 4.12 | 4.66 | 4.5 | 4.45 | |||||
Dividend Per Share | 4.62 | 4.74 | 4.9 | 5.04 | 5.14 | |||||
Payout Ratio | 99.67 | 91.41 | 83.21 | 86.34 | 101.93 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 11.83B | 12.7B | 14.07B | 13.58B | 14.1B | |||||
EBITA | 10.93B | 11.79B | 13.17B | 12.67B | 13.19B | |||||
EBIT | 10.86B | 11.72B | 13.08B | 12.4B | 12.7B | |||||
EBITDAR | 12.16B | 13.02B | 14.41B | 13.92B | 14.45B | |||||
Total Revenues (As Reported) | 29.8B | 28.69B | 31.4B | 31.76B | - | |||||
Effective Tax Rate - (Ratio) | 22.88 | 21.67 | 21.57 | 19.06 | 22.05 | |||||
Current Domestic Taxes | 17M | -80M | 73M | -75M | 201M | |||||
Current Foreign Taxes | 2.42B | 2.6B | 2.62B | 2.55B | 2.47B | |||||
Total Current Taxes | 2.43B | 2.52B | 2.69B | 2.48B | 2.67B | |||||
Deferred Domestic Taxes | 24M | 53M | 27M | -139M | -368M | |||||
Deferred Foreign Taxes | -165M | -196M | -45M | -95M | 38M | |||||
Total Deferred Taxes | -141M | -143M | -18M | -234M | -330M | |||||
Normalized Net Income | 5.98B | 6.41B | 7.27B | 6.99B | 6.92B | |||||
Interest on Long-Term Debt | - | - | 1M | 1M | 1M | |||||
Non-Cash Pension Expense | -18M | -14M | -1M | -93M | -84M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 730M | 637M | 807M | 777M | 965M | |||||
Research And Development Expense From Footnotes | 465M | 495M | 617M | 642M | 709M | |||||
Net Rental Expense, Total | 332M | 317M | 339M | 330M | 353M | |||||
Imputed Operating Lease Interest Expense | 66.52M | 57.65M | 65.98M | 56.26M | 93.2M | |||||
Imputed Operating Lease Depreciation | 265M | 259M | 273M | 274M | 260M | |||||
Stock-Based Comp., Other (Total) | 172M | 167M | 210M | 183M | 212M | |||||
Total Stock-Based Compensation | 172M | 167M | 210M | 183M | 212M |